About ApoCell
ApoCell is a company based in Houston (United States) founded in 2004 was acquired by Precision Medicine Group in October 2018. The company has 2,198 employees as of December 31, 2022. ApoCell offers products and services including Clinical Trial Management, Lab Services, and Biospecimens. ApoCell operates in a competitive market with competitors including BioAgilytix, Alderley Analytical, Tentamus, Nordic Bioscience and Solvias, among others.
- Headquarter Houston, United States
- Employees 2198 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Precision Medicine Group, Llc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Precision Medicine Group
& 1 more
-
Employee Count
2198
as on Dec 31, 2022
-
Acquired by
Precision Medicine Group
(Oct 16, 2018)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of ApoCell
ApoCell offers a comprehensive portfolio of products and services, including Clinical Trial Management, Lab Services, and Biospecimens.
Manages trials for drug development in oncology.
Provides biomarker analysis and immune monitoring.
Supplies tissues and fluids for research purposes.
Funding Insights of ApoCell
Investors in ApoCell
ApoCell has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Precision Medicine Group and Summit Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Summit Partners is recognized as a growth equity investment firm.
|
Locked | Locked | Locked | |
|
Provider of clinical research, development, and commercialization services for life sciences
|
Locked | Locked | Locked |
Investor details for ApoCell
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by ApoCell
Investment portfolio details for ApoCell
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - ApoCell
Detailed financials for ApoCell
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Apocell Comparisons
Peer comparison for ApoCell
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of ApoCell
ApoCell operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BioAgilytix, Alderley Analytical, Tentamus, Nordic Bioscience and Solvias, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Large-molecule bioanalysis is provided for biologics and biosimilars development.
|
|
| Locked | Locked | Locked |
Bioanalytical assays for drug development are developed and validated.
|
|
| Locked | Locked | Locked |
Analytical and quality assurance services are provided for diverse industries.
|
|
| Locked | Locked | Locked |
Preclinical and clinical drug development CRO with proprietary in-house Biomarker platform
|
|
| Locked | Locked | Locked |
Integrated R&D services are provided for pharmaceuticals and allied sectors.
|
|
| Locked | Locked | Locked |
Microfluidics and mass spectrometry products are provided for clinical research.
|
Detailed competitors of ApoCell
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Apocell
Complete news archive for ApoCell
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ApoCell
ApoCell was founded in 2004 and raised its 1st funding round 5 years after it was founded.
ApoCell is headquartered in Houston, United States. It is registered at Houston, Texas, United States.
Mark Clein is the current CEO of ApoCell.
As of Dec 31, 2022, the latest employee count at ApoCell is 2,198.
ApoCell is a provider of tools for molecular profiling and diagnostics of tumor cells. It provides tools for molecular profiling and diagnostics for the biopharma industry and other translational medical groups. The company specializes in rare cell analysis, specifically in characterizing circulating tumor cells. It has developed ApoStream that distinguish CTCs from healthy blood cells through dielectrophoresis (DEP) and microfluidics. In addition, the company also provides services for functional biomarker analysis, single-cell protein analysis, and other traditional genomic analyses. ApoCell conducts sample analyses for clinical trials and also develops assays for the same.
ApoCell's top competitors include Alderley Analytical, BioAgilytix and Lightcast Discovery.
ApoCell offers Clinical Trial Management, Lab Services, and Biospecimens.
ApoCell has 2 investors. Key investors include Precision Medicine Group, and Summit Partners.